PureTech Health plc SEC filings PRTCY

PureTech Health plc has 134 filings in SEC EDGAR's recent list, going back to Sep 22, 2020. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on May 1, 2026. The company's fiscal year ends on December 31.

PureTech Health plc SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) May 1, 2026 May 1, 2026
6-K Current report (foreign issuer) Apr 29, 2026 Apr 29, 2026
6-K Current report (foreign issuer) Apr 29, 2026 Apr 29, 2026
6-K Current report (foreign issuer) Dec 18, 2025 Dec 18, 2025
6-K Current report (foreign issuer) Dec 10, 2025 Dec 10, 2025
6-K Current report (foreign issuer) Aug 28, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Jul 16, 2025 Jul 16, 2025
6-K Current report (foreign issuer) Jul 8, 2025 Jul 8, 2025
6-K Current report (foreign issuer) Jun 16, 2025 Jun 16, 2025
6-K Current report (foreign issuer) Apr 30, 2025 Apr 30, 2025
6-K Current report (foreign issuer) Apr 7, 2025 Apr 7, 2025
6-K Current report (foreign issuer) Dec 16, 2024 Dec 16, 2024
6-K Current report (foreign issuer) Oct 21, 2024 Oct 21, 2024
6-K Current report (foreign issuer) Sep 27, 2024 Sep 27, 2024
6-K Current report (foreign issuer) Aug 28, 2024 Aug 28, 2024
6-K Current report (foreign issuer) Aug 28, 2024 Jun 30, 2024
6-K Current report (foreign issuer) Aug 22, 2024 Aug 22, 2024
6-K Current report (foreign issuer) Jun 24, 2024 Jun 24, 2024
6-K Current report (foreign issuer) Jun 20, 2024 Jun 20, 2024
6-K Current report (foreign issuer) Jun 13, 2024 Jun 13, 2024
6-K Current report (foreign issuer) Jun 6, 2024 Jun 6, 2024
6-K Current report (foreign issuer) Jun 4, 2024 Jun 4, 2024
6-K Current report (foreign issuer) May 29, 2024 May 29, 2024
6-K Current report (foreign issuer) May 20, 2024 May 20, 2024
6-K Current report (foreign issuer) Apr 25, 2024 Apr 25, 2024
6-K Current report (foreign issuer) Apr 9, 2024 Apr 9, 2024
6-K Current report (foreign issuer) Mar 19, 2024 Mar 19, 2024
6-K Current report (foreign issuer) Mar 18, 2024 Mar 18, 2024
6-K Current report (foreign issuer) Mar 4, 2024 Feb 29, 2024
6-K Current report (foreign issuer) Feb 5, 2024 Jan 31, 2024
6-K Current report (foreign issuer) Jan 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Dec 20, 2023 Dec 20, 2023
6-K Current report (foreign issuer) Dec 5, 2023 Dec 5, 2023
6-K Current report (foreign issuer) Nov 2, 2023 Nov 2, 2023
6-K Current report (foreign issuer) Oct 3, 2023 Oct 3, 2023
6-K Current report (foreign issuer) Sep 6, 2023 Sep 6, 2023
6-K Current report (foreign issuer) Aug 29, 2023 Jun 30, 2023
6-K Current report (foreign issuer) Aug 2, 2023 Aug 2, 2023
6-K Current report (foreign issuer) Jul 6, 2023 Jul 6, 2023
6-K Current report (foreign issuer) Jun 14, 2023 Jun 13, 2023
6-K Current report (foreign issuer) Jun 12, 2023 Jun 12, 2023
6-K Current report (foreign issuer) Jun 2, 2023 Jun 2, 2023
6-K Current report (foreign issuer) May 3, 2023 May 3, 2023
6-K Current report (foreign issuer) Apr 28, 2023 Apr 28, 2023
6-K Current report (foreign issuer) Apr 4, 2023 Apr 4, 2023
6-K Current report (foreign issuer) Mar 23, 2023 Mar 23, 2023
6-K Current report (foreign issuer) Mar 20, 2023 Mar 20, 2023
6-K Current report (foreign issuer) Mar 2, 2023 Mar 2, 2023
6-K Current report (foreign issuer) Feb 3, 2023 Jan 31, 2023
6-K Current report (foreign issuer) Dec 22, 2022 Dec 22, 2022
6-K Current report (foreign issuer) Dec 2, 2022 Nov 30, 2022
6-K Current report (foreign issuer) Nov 10, 2022 Nov 10, 2022
6-K Current report (foreign issuer) Nov 3, 2022 Nov 3, 2022
6-K Current report (foreign issuer) Oct 11, 2022 Oct 11, 2022
6-K Current report (foreign issuer) Oct 7, 2022 Oct 7, 2022
6-K Current report (foreign issuer) Oct 4, 2022 Sep 30, 2022
6-K Current report (foreign issuer) Sep 2, 2022 Aug 31, 2022
6-K Current report (foreign issuer) Aug 25, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Aug 22, 2022 Aug 22, 2022
6-K Current report (foreign issuer) Aug 9, 2022 Aug 9, 2022
6-K Current report (foreign issuer) Aug 4, 2022 Jul 31, 2022
6-K Current report (foreign issuer) Jul 5, 2022 Jun 30, 2022
6-K Current report (foreign issuer) Jun 15, 2022 Jun 15, 2022
6-K Current report (foreign issuer) Jun 3, 2022 Jun 3, 2022
6-K Current report (foreign issuer) May 9, 2022 May 9, 2022
6-K Current report (foreign issuer) May 5, 2022 May 5, 2022
6-K Current report (foreign issuer) Apr 26, 2022 Apr 26, 2022
6-K Current report (foreign issuer) Mar 24, 2022 Mar 24, 2022
6-K Current report (foreign issuer) Jan 26, 2022 Jan 26, 2022
6-K Current report (foreign issuer) Jan 14, 2022 Jan 14, 2022
6-K Current report (foreign issuer) Nov 10, 2021 Nov 10, 2021
6-K Current report (foreign issuer) Nov 9, 2021 Nov 9, 2021
6-K Current report (foreign issuer) Oct 12, 2021 Oct 12, 2021
6-K Current report (foreign issuer) Aug 24, 2021 Jun 30, 2021
6-K Current report (foreign issuer) Jul 19, 2021 Jul 19, 2021
6-K Current report (foreign issuer) May 27, 2021 May 27, 2021
6-K Current report (foreign issuer) Mar 18, 2021 Mar 18, 2021
6-K Current report (foreign issuer) Mar 15, 2021 Mar 15, 2021
6-K Current report (foreign issuer) Feb 10, 2021 Feb 10, 2021
6-K Current report (foreign issuer) Feb 5, 2021 Feb 5, 2021
6-K Current report (foreign issuer) Jan 29, 2021 Jan 29, 2021

Showing 81 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTCHF (OTC), PRTCY (OTC)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Boston, MA
SEC filer status
Accelerated filer
SEC CIK
1782999

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.